topotecan hydrochloride
NDC 16729-151, topotecan hydrochloride, injection, powder, lyophilized, for solution, from Accord Healthcare, Inc..
- Product NDC
- 16729-151
- Status
- Listed
- Labeler
- Accord Healthcare, Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA202351
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/16729-151 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOPOTECAN HYDROCHLORIDE4 mg/4mL
Pharmacologic classes
Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 16729-151-31 | 16729015131 | 1 VIAL in 1 PACKAGE (16729-151-31) / 4 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/729b2b22-1344-44f3-b614-14f6ec3c263eMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=16729-151
Use it
Look up 16729-151 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/16729-151 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 16729-151. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.